Search

everythinglearnresearchcommunity

for

Search:↓

Cepharanthine effectively reduces Herpes Simplex Virus Type 1 by blocking certain cell pathways and promoting cell death.

A man developed neurological issues from SARS-CoV-2 without severe breathing problems, worsening to death.

SARS-CoV-2 might infect and multiply in skin tissue, possibly aiding in its transmission.

COVID-19 can cause a temporary hair loss condition.

Cepharanthine and tetrandrine show promise as COVID-19 drugs.

Cancer patients with COVID-19 face higher risks due to possible additional infections.

Continued vaccine and drug development is crucial due to new virus variants and regional infection spikes.

A fungal skin infection was successfully treated with medication and compression therapy.

Some Moroccan medicinal plants may contain compounds that can inhibit the virus causing COVID-19.

Targeting endolysosomes may help treat COVID-19.

A prostate cancer drug can lower the levels of a protein that the coronavirus uses to enter lung cells.

COVID-19 vaccination may trigger lupus in some people.

New compounds effective against SARS-CoV-2 variants were identified using a rapid testing method with human lung cells.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

Surgical excision is the best treatment for SCC.

COVID-19 may cause early hair loss by infecting hair follicles.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

Patients with lupus nephritis and COVID-19 can improve with proper treatment.

Lecithin-encapsulated resveratrol nanoparticles could be a safe and effective anti-cancer treatment.

TMPRSS2 is crucial for COVID-19 infection and is a potential target for treatment.

Four drugs were found that could potentially treat COVID-19 by inhibiting the virus in lab tests.

Human placenta hydrolysate may help treat COVID-19 by reducing virus replication and boosting immune response.

Intralesional cidofovir may be a viable treatment for conjunctival lesions in Melkersson-Rosenthal syndrome without systemic toxicity.

The combined Selencin treatment effectively reduces hair loss and improves hair health after COVID-19.

Fosravuconazole effectively treated a woman's scalp infection without side effects.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

Cellular senescence has both cancer-blocking and cancer-promoting effects, and targeting senescent cells may improve health and lifespan.

Five FDA-approved drugs may help block COVID-19 virus entry.